The emergence of COVID-19 variant BA.3.2, known as “Cicada,” is raising concerns among health officials in the United States and globally. This variant is prompting increased tracking and monitoring due to a steady rise in cases.
Overview of COVID Variant BA.3.2 ‘Cicada’
Cicada is a highly mutated variant of the SARS-CoV-2 virus. It was first identified in November 2024 in South Africa. The CDC initiated tracking of BA.3.2 in the U.S. following a notable rise in cases reported in March 2025.
- First Detection: June 2025 (travel to the U.S.)
- First U.S. Case: January 2026
- Mutation Details: 70-75 mutations distinct from the JN.1 lineage
Global Spread of BA.3.2
As of March 2025, BA.3.2 has been detected in over 20 countries. It accounts for approximately 30% of cases in some regions. Notably, it has caused spikes in countries like Germany, Denmark, and the Netherlands.
The CDC reports BA.3.2 presence across 25 U.S. states, including:
- California
- Florida
- New York
- Texas
- Virginia
Recent data shows BA.3.2 was found in 3.7% of wastewater samples as of mid-March, competing against the dominant XFG variant, which holds 53% of samples.
Symptoms Associated with Cicada Variant
Symptoms of the Cicada variant closely mirror those of earlier COVID-19 strains. These may include:
- Runny or stuffy nose
- Headache
- Fatigue
- Sore throat
- Coughing
Notably, reports have indicated that severe throat pain may be more common than in previous variants, but overall severity remains comparable.
Preventative Measures and Recommendations
Despite potential changes in vaccine effectiveness due to mutations, vaccination remains critical. Current COVID-19 vaccines and boosters can provide significant protection against severe outcomes. Recommendations include:
- Get tested if symptomatic or if you suspect exposure.
- Isolate at home if testing positive until cleared.
- Wear a high-quality mask, such as N95, in crowded settings.
- Stay current with vaccinations.
It is essential for individuals to monitor symptoms and seek advice from healthcare providers as needed. Hygiene practices, such as handwashing and cleaning shared surfaces, continue to be vital in controlling the spread of the virus.
